Nivedya Swarnalekha

Nivedya Swarnalekha

Auto-generated profile, based on publicly available information

Nivedya Swarnalekha

Immune Cell Biology Laboratory, Department of Biomedicine, University of Basel, University Hospital Basel, CH-4031 Basel, Switzerland

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2021 in Science Immunology
Verified
Journal Article
Closed access
PDF file
NSNivedya Swarnalekha
Nivedya Swarnalekha
DSDavid Schreiner
David Schreiner
LLLudivine C. Litzler
Ludivine C. Litzler
SISaadia Iftikhar
Saadia Iftikhar
DKDaniel Kirchmeier
Daniel Kirchmeier
CKCarolyn G. King
Carolyn G. King
Influenza is a deadly and costly infectious disease, even during flu seasons when an effective vaccine has been developed. To improve vaccines against respiratory viruses, a better understanding of the immune response at the site of infection is crucial. After influenza infection, clonally expanded T cells take up permanent residence in the lung, poised to rapidly respond to subsequent infection. Here, we characterized the dynamics and transcriptional regulation of lung-resident CD4+ T cells during influenza infection and identified a long-lived, Bcl6-dependent population that we have termed T resident helper (TRH) cells. TRH cells arise in the lung independently of lymph node T follicular helper cells but are dependent on B cells, with which they tightly colocalize in inducible bronchus-associated lymphoid tissue (iBALT). Deletion of Bcl6 in CD4+ T cells before heterotypic challenge infection resulted in redistribution of CD4+ T cells outside of iBALT areas and impaired local antibody production. These results highlight iBALT as a homeostatic niche for TRH cells and advocate for vaccination strategies that induce TRH cells in the lung.

13 March 2020 in Science Immunology
Verified
Journal Article
Closed access
PDF file
MKMarco Künzli
Marco Künzli
DSDavid Schreiner
David Schreiner
TPTamara C. Pereboom
Tamara C. Pereboom
NSNivedya Swarnalekha
Nivedya Swarnalekha
LLLudivine C. Litzler
Ludivine C. Litzler
CKCarolyn G. King
Carolyn G. King
T follicular helper (T fh ) cells are long lived and contribute to the maintenance of sustained humoral immunity.

6 March 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
MFMarianna Florova
Marianna Florova
TATiago Abreu-Mota
Tiago Abreu-Mota
GPGuido C. Paesen
Guido C. Paesen
ABAnna Sophia Beetschen
Anna Sophia Beetschen
KCKaren Cornille
Karen Cornille
DPDaniel Pinschewer
Daniel Pinschewer
Viral mimicry of host cell structures has been postulated to curtail the B cell receptor (BCR) repertoire against persisting viruses through tolerance mechanisms. This concept awaits, however, experimental testing in a setting of natural virus–host relationship. We engineered mouse models expressing a monoclonal BCR specific for the envelope glycoprotein of lymphocytic choriomeningitis virus (LCMV), a naturally persisting mouse pathogen. When the heavy chain of the LCMV-neutralizing antibody KL25 was paired with its unmutated ancestor light chain, most B cells underwent receptor editing, a behavior reminiscent of autoreactive clones. In contrast, monoclonal B cells expressing the same heavy chain in conjunction with the hypermutated KL25 light chain did not undergo receptor editing but exhibited low levels of surface IgM, suggesting that light chain hypermutation had lessened KL25 autoreactivity. Upon viral challenge, these IgMlowcells were not anergic but up-regulated IgM, participated in germinal center reactions, produced antiviral antibodies, and underwent immunoglobulin class switch as well as further affinity maturation. These studies on a persisting virus in its natural host species suggest that central tolerance mechanisms prune the protective antiviral B cell repertoire.